Endocrine System Channel
Related Channels


Nateglinide and Hemoglobin A1c
Hemoglobin A1c (HbA1c) is a test used to measure long-term blood sugar control. For people without diabetes, HbA1c results are usually less than 6 percent, while people with diabetes usually have higher results. In one study, people taking nateglinide lowered their HbA1c by up to 0.5 percent on average, while people not taking the drug increased their HbA1c by 0.2 percent.
Studies have shown that the higher the HbA1c, the greater the chance of developing long-term problems related to diabetes. This includes problems such as:
By getting blood sugar levels under control, it may be possible to decrease the chances of developing these diabetes-related complications.
Nateglinide and Fasting Blood Sugar
Fasting blood sugar is another way to study the effects of diabetes drugs. In studies, people taking nateglinide decreased their fasting blood sugar levels by up to 13.6 mg/dL, while people not taking it increased their fasting blood sugar levels.

When and How to Take Nateglinide

General considerations to keep in mind during treatment with nateglinide include the following:
  • Nateglinide comes in tablet form. It should be taken by mouth before each meal.
  • The drug can be taken up to half an hour before each meal. However, if you skip a meal, you should also skip your dose of nateglinide.
  • For the medication to work properly, it must be taken as prescribed. Nateglinide will not work if you stop taking it.
Steps to Prevent or Delay Diabetic Nerve Damage

Nateglinide for Diabetes

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.